Schedule 13G ownership disclosure

ACADIA Pharmaceuticals Inc

Security class unavailable · CUSIP: 004225108

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,757,952
Percent of class
4.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000215457-16-006408
Form type
SC 13G/A
Filer
ACADIA PHARMACEUTICALS INC
CIK
CIK 1070494
Filed
Jul 08, 2016
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub